دورية أكاديمية

Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition

التفاصيل البيبلوغرافية
العنوان: Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition
المؤلفون: Jenab, Mazda, Riboli, Elio, Cleveland, Rebecca J., Norat, Teresa, Rinaldi, Sabina, Nieters, Alexandra, Biessy, Carine, Tjonneland, Ann, Olsen, Anja, Overvad, Kim, Gronbaek, Henning, Clavel-Chapelon, Francoise, Boutron-Ruault, Marie-Christine, Linseisen, Jakob, Boeing, Heiner, Pischon, Tobias, Trichopoulos, Dimitrios, Oikonomou, Eleni, Trichopoulou, Antonia, Panico, Salvatore, Vineis, Paolo, Berrino, Franco, Tumino, Rosario, Masala, Giovanna, Peters, Petra H., van Gils, Carla H., Bueno-de-Mesquita, H. Bas, Ocke, Marga C., Lund, Eiliv, Mendez, Michelle A., Tormo, Maria Jose, Barricarte, Aurelio, Martinez-Garcia, Carmen, Dorronsoro, Miren, Ramon Quiros, Jose, Hallmans, Goran, Palmqvist, Richard, Berglund, Göran, Manjer, Jonas, Key, Timothy, Allen, Naomi E., Bingham, Sheila, Khaw, Kay-Tee, Cust, Anne, Kaaks, Rudolf
المصدر: International Journal of Cancer; 121(2), pp 368-376 (2007) ; ISSN: 0020-7136
بيانات النشر: John Wiley & Sons Inc.
سنة النشر: 2007
المجموعة: Lund University Publications (LUP)
مصطلحات موضوعية: Cancer and Oncology, EPIC, C-peptide, insulin, colorectal cancer, IGF
الوصف: Western style diets and lifestyles are associated with increasing rates of obesity, diabetes and insulin resistance. Higher circulating insulin levels may modulate cell proliferation and apoptosis either directly or indirectly by increasing the bioactivity of IGF-I and decreasing the bioactivity of some of its binding proteins. The objective of this study was to determine the association of increasing levels of serum C-peptide, a biomarker of pancreatic insulin secretion, and IGF binding proteins (IGFBP) -1 and -2 with colorectal cancer risk in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), a large cohort involving 10 Western European countries. A total of 1,078 colorectal cancer cases were matched (age, date of blood donation, fasting status, gender, study center) to an equal number of control subjects. Relative cancer risks were estimated using conditional logistic regression models. Serum C-peptide concentration was positively associated with an increased colorectal cancer risk for the highest versus the lowest quintile (OR = 1.56, 95% CI = 1.16-2.09, p(trend) < 0.01), which was slightly attenuated after adjustment for BMI and physical activity (OR = 1.37, 95% CI = 1.00-1.88, p(trend) = 0.10). When stratified by anatomical site, the cancer risk was stronger in the colon (OR 1.67, 95% CI = 1.14-2.46, p(trend) < 0.01) than in the rectum (OR 1.42, 95% CI = 0.90-2.25, p(trend) = 0.35). The cancer risk estimates were not heterogeneous by gender or fasting status. No clear colorectal cancer risk associations were observed for IGFBP-1 or -2. This large prospective study confirms that hyperinsulinemia, as determined by C-peptide levels, is associated with an increased colorectal cancer risk. (C) 2007 Wiley-Liss, Inc.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://lup.lub.lu.se/record/650999Test; http://dx.doi.org/10.1002/ijc.22697Test; wos:000247155000019; scopus:34250321324; pmid:17372899
DOI: 10.1002/ijc.22697
الإتاحة: https://doi.org/10.1002/ijc.22697Test
https://lup.lub.lu.se/record/650999Test
رقم الانضمام: edsbas.70133B0A
قاعدة البيانات: BASE